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Topic Signiﬁcance & Study Purpose/Background/Rationale:
The Blood andMarrow Transplant (BMT) patient population is
highly susceptible to acquiring a Clostridium difﬁcile (c. diff)
infection. The prolonged neutropenic status causes c. diff in-
fections to be more severe and longer lasting in this patient
population (Rev Inst Med Trop Sao Paulo. 2014 Jul;56(4):325-
31). On average, the cost of a Hospital Acquired Infection (HAI)
of c. diff is $11,285 per incident (JAMA Intern Med 2013;
173(22)2039-2046). The current practice of sanitizing with
bleach wipes with all patients has minimal effect on c. diff
rates (Clin Infect Dis. (2000) 31 (4): 995-1000).
Methods, Intervention, & Analysis: Starting November
2013, the University of Minnesota Health Adult BMT unit
experienced an increased prevalence of c. diff in the inpatient
population. As a result, the unit switched their sanitizing
practices to universally sanitizing with a hypochlorite solu-
tion. Previously, only rooms of patients testing positive for a
c. diff infection were sanitized with a hypochlorite solution.
This switch did not result in a signiﬁcant drop in c. diff rates
per one thousand patient days. In February, a silver based
solution (Steriplex SD & Steriplex 360) was adopted unit
wide to replace the hypochlorite solution. The use of all other
sanitizing products was discontinued. C. diff rates were
measured by patient lab reports.
Findings & Interpretation: Findings demonstrated that the
switch to silver basedwipes from bleach based wipes reduced
c. diff infection rates among the BMT population, as demon-
strated by the drop in the rate of active c. diff from 5.5/1000
patient days to 0/1000 patient days. The current hospital
practice to reduce the transmission of active c. diff infection is
the use of bleach based wipes. Implications of the study
include: ongoing advocacy of improved infection prevention
measures in the care of BMT patients, further conversations
with the infection control department about c. diff infection
control practices in the BMT population, as well as consider-
ation for switching disinfection products hospital wide.
Discussion & Implications: Based on these ﬁndings, we
have switched solely to sanitizing with the silver-based so-
lution. We recommend the use of this solution to the
outpatient BMT clinic. This practice would be beneﬁcial in
protecting all patient populations including those with he-
matological/oncological conditions.569
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Hematopoietic transplantation is a complex procedure.
Excellent education and discussionwith patients and family is
imperative because of increasingly complicated clinical and
psychosocial management of their care. In the early steps of
pre-transplant preparation, before admission, it is important
to initiate discussion with the patient and family about
discharge teaching. This was important when moving autol-
ogous transplant in outpatient day hospital.To discuss process of patient/caregiver evaluation and
caregiver support during patient day hospital visits: 1) the
implementation of Pre transplant Caregiver education; 2)
identify speciﬁc content areas for pre-transplant teaching; 3)
additional methods of teaching involving both patient and
caregiver.
Methods, Intervention, & Analysis: A group was formed to
develop Day Hospital HCT Discharge Teaching to: 1)
improve patient/family caregiver education about outpa-
tient HCT multiple myeloma in the day hospital; 2) create
content and develop methods for patient & caregiver edu-
cation in preparation for admission to the Day Hospital and
3) develop and adminster satisfaction survey of new OPD
transplant process.
Findings & Interpretation: A task force of staff nurses, nurse
practitioner, nurse educators, nursing leaders, case managers,
and clinical social workerwas assembled to develop caregiver
education which included the caregiver attending a group
class facilitated by a nurse coordinator; caregiver contract;
and complete symptom management forms. In addition,
nurse coordinators and day hospital staff review speciﬁc
content for HCT patient care, common medications and side
effects, expected transplant related symptoms, discharge is-
sues which include VAD care, infection precautions, dietary
restrictions, home preparation, clinic routine, and long term
survivorship topics with the caregiver. With the pre-trans-
plant education, patient and caregiver satisfactionwas high at
day of transplant (caregiver 90.3%, patient 91.8%) and at day of
discharge (patient only 90%); with these efforts, it achieved a
decrease in the HCT number of length of stay days from 21
days to 14 days. Ninety two percent of patients (n¼12)
received their stem cells in an outpatient setting.
Discussion & Implications: There was improved coopera-
tion between physician/mid-level/nursing teams resulting in
timely and efﬁcient care and cooperation between outpa-
tient and inpatient; patient obtained prescribed medication
100% and patient expressed quality of life is better main-
tained. The institutional commitment to the program has
promoted seamless care.570
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Advances in the design of CVCs has led to a variety of features
that increase the functionality of CVCs used in the care of BMT
patients. Examples of these features include: power injection
of contrast media, central venous pressure (CVP) monitoring,
apheresis procedures including stem cell collection, plasma
exchange and extracorporeal photopheresis. However,
matching the right CVC with the individual treatment re-
quirements for BMT patients can be a challenge. For example,
CVC’s composed of polyurethane are not recommended for
infusion containing high concentrations of alcohol (e.g., un-
diluted etoposide). At our institution, an opportunity for
improvement was identiﬁed due to an increase in occurrences
of inappropriate CVC selection. The decision to develop a
nurse-initiated protocol was based on the knowledge of
infusion therapy.
